DV
Dividend Vision

BIIB — Biogen Inc.

Biogen Inc. (BIIB)

Its deepest 1-year drawdown was 14.3%.

BIIB is a single-stock equity holding in Biogen Inc., a biotechnology company, rather than a diversified ETF fund. The stock distributes dividends on a quarterly basis, though specific yield and expense ratio data are not currently available. This holding appeals primarily to investors seeking exposure to a specific biotechnology company with dividend income, rather than those pursuing diversified dividend portfolio strategies.

BIIB key facts

Asset type
Stock
Asset class
Equity
Inception date
09/17/1991
Distribution frequency
None
Last close
$209.83
Market cap
$31,003,222,016
Average volume
554400.0
Beta
0.162
Payout ratio
0.0
P/E ratio
37.3363
Forward P/E
16.9779
EPS
$5.62